On December 10, 2020, Sanofi signed a renewed partnership agreement with the World Health Organization to eliminate sleeping sickness by 2030.
Sanofi is working to address gaps in childhood cancer care. In R&D, we are focused on developing potential therapies to eliminate childhood cancer deaths and accelerate the clinical trial timeline while building partnerships with leading scientific institutions. At the same time our philanthropic platform, Foundation S, is committed to improve survival rates of children with cancer in LMICs through its existing ‘My Child Matters’ program.
We’re the first global supplier of the injectable polio vaccine and have been fighting to eradicate polio for over 40 years. Since 1988, Sanofi has been a key partner of the Global Polio Eradication Initiative and has supplied billions of doses of Polio Vaccine in the world.
Journey towards polio eradication over the last decade
- https://www.who.int/news-room/fact-sheets/detail/cancer-in-children (Accessed March 2021)
- https://www.who.int/news-room/fact-sheets/detail/cancer-in-children (Accessed on March 2023)
- World Health Organization. (2020). Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. World Health Organization. https://apps.who.int/iris/handle/10665/331452 (Accessed March 2023)